White Papers

The Opioid Crisis: A Lesson in Adaptation

Posted October 17, 2017| Tanya Chotibut

There is an over-reliance on opioid medications within the U.S., with alarming increases in diversion, overdose, and addiction and it has created the opioid epidemic.

As it stands now, opioid analgesics are the most commonly prescribed class of medications in the United States with more than 30 percent of Americans suffering from some form of acute or chronic pain.  

This whitepaper outlines the opioid epidemics and the related issues for pharma companies while offering a high-level solution for pharma companies to consider as they move products through the life-cycle. Solutions are not limited to post-marketing surveillance and implementing adaptive trials with more data integration and the use of predictive analytics.

Download the Whitepaper:



Tags: , , , ,

Related Resources

Read More

2019 Pharma Companies to Watch Report

This proprietary qualitative analysis identifies five top pharmaceutical companies that stand out as major disruptors. Fuld + Company’s analysis includes […]

Read More

Competitive Intelligence (CI) Dictionary

Competitive Intelligence is the collection and analysis of information to anticipate competitive activity, see past market disruptions and dispassionately interpret […]

Read More

Early Warning & Scenario Analysis Toolkit

Conduct Scenario Analysis and establish an early warning system that keeps your company one step ahead of market trends + competitors. […]

Subscribe to our mailing list for our latest updates: